1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	394_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	394_QUEST_clinical_caseMIR	SENT1	-	-
3	72	72		-	-	10-12	394_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	394_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	18-20	394_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	21-25	394_QUEST_clinical_caseMIR	SENT1	-	-
7	que	que	PR0CN000	-	-	26-29	394_QUEST_clinical_caseMIR	SENT1	-	-
8	refiere	referir	VMIP3S0	-	-	30-37	394_QUEST_clinical_caseMIR	SENT1	-	-
9	clínica	clínica	NCFS000	C0442592	medio_ambiente	38-45	394_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0332285	atributo	46-48	394_QUEST_clinical_caseMIR	SENT1	-	-
11	dolor	dolor	NCMS000	C0024031_1	trastorno_1	49-54	394_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	lumbar	lumbar	NC00SC0	C0024031_2	trastorno_2	55-61	394_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
13	y	y	CC	C1706368	calificador	62-63	394_QUEST_clinical_caseMIR	SENT1	-	-
14	astenia	astenia	NCFS000	C0004093#C3714552	hallazgo	64-71	394_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	72-74	394_QUEST_clinical_caseMIR	SENT1	-	-
16	las	el	DA0FP0	-	-	75-78	394_QUEST_clinical_caseMIR	SENT1	-	-
17	últimas	último	AO0FP0	-	-	79-86	394_QUEST_clinical_caseMIR	SENT1	-	-
18	semanas	semana	NCFP000	C0439230	calificador	87-94	394_QUEST_clinical_caseMIR	SENT1	-	-
19	.	.	Fp	-	-	94-95	394_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	96-98	394_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	99-101	394_QUEST_clinical_caseMIR	SENT2	-	-
3	analítica	analítica	NCFS000	-	-	102-111	394_QUEST_clinical_caseMIR	SENT2	-	-
4	se	se	P00CN000	-	-	112-114	394_QUEST_clinical_caseMIR	SENT2	-	-
5	objetiva	objetivar	VMIP3S0	-	-	115-123	394_QUEST_clinical_caseMIR	SENT2	-	-
6	Hb	hb	NC00YL0	-	-	124-126	394_QUEST_clinical_caseMIR	SENT2	-	-
7	de	de	SPS00	C0332285	atributo	127-129	394_QUEST_clinical_caseMIR	SENT2	-	-
8	10	10	Z	-	-	130-132	394_QUEST_clinical_caseMIR	SENT2	-	-
9	g	g	NCMN000	-	-	133-134	394_QUEST_clinical_caseMIR	SENT2	-	-
10	/	/	Fh	-	-	134-135	394_QUEST_clinical_caseMIR	SENT2	-	-
11	dL	decilitro	NCMN000	C0439241	calificador	135-137	394_QUEST_clinical_caseMIR	SENT2	-	-
12	,	,	Fc	-	-	137-138	394_QUEST_clinical_caseMIR	SENT2	-	-
13	VCM	vcm	NC00SC0	C0524587	entidad_observable	139-142	394_QUEST_clinical_caseMIR	SENT2	-	-
14	82	82		-	-	143-145	394_QUEST_clinical_caseMIR	SENT2	-	-
15	fL	fl	NC00SC0	C0475213	calificador	146-148	394_QUEST_clinical_caseMIR	SENT2	-	-
16	,	,	Fc	-	-	148-149	394_QUEST_clinical_caseMIR	SENT2	-	-
17	VSG	velocidad_de_sedimentación_globular	NC00YL0	-	-	150-153	394_QUEST_clinical_caseMIR	SENT2	-	-
18	110	110	Z	-	-	154-157	394_QUEST_clinical_caseMIR	SENT2	-	-
19	mm	mm	NCMN000	-	-	158-160	394_QUEST_clinical_caseMIR	SENT2	-	-
20	/	/	Fh	-	-	160-161	394_QUEST_clinical_caseMIR	SENT2	-	-
21	h	hora	NCMN000	C0040223#C0439227	calificador	161-162	394_QUEST_clinical_caseMIR	SENT2	-	-
22	,	,	Fc	-	-	162-163	394_QUEST_clinical_caseMIR	SENT2	-	-
23	creatinina	creatinina	NC00SC0	C0010294	sustancia	164-174	394_QUEST_clinical_caseMIR	SENT2	-	-
24	de	de	SPS00	C0332285	atributo	175-177	394_QUEST_clinical_caseMIR	SENT2	-	-
25	2,5	2.5	Z	-	-	178-181	394_QUEST_clinical_caseMIR	SENT2	-	-
26	mg	mg	NCMN000	-	-	182-184	394_QUEST_clinical_caseMIR	SENT2	-	-
27	/	/	Fh	-	-	184-185	394_QUEST_clinical_caseMIR	SENT2	-	-
28	dL	decilitro	NCMN000	C0439241	calificador	185-187	394_QUEST_clinical_caseMIR	SENT2	-	-
29	y	y	CC	C1706368	calificador	188-189	394_QUEST_clinical_caseMIR	SENT2	-	-
30	proteinuria	proteinuria	NCFS000	C0033687_1	hallazgo_1	190-201	394_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
31	de	de	SPS00	C0332285	atributo	202-204	394_QUEST_clinical_caseMIR	SENT2	-	-
32	cadenas	cadena	NCFP000	C3540771#C0337112	metadato_fundacional#objeto_físico	205-212	394_QUEST_clinical_caseMIR	SENT2	-	-
33	ligeras	ligero	AQ0FP0	-	-	213-220	394_QUEST_clinical_caseMIR	SENT2	-	-
34	Kappa	kappa	NCFS000	C0439099	calificador	221-226	394_QUEST_clinical_caseMIR	SENT2	-	-
35	de	de	SPS00	C0332285	atributo	227-229	394_QUEST_clinical_caseMIR	SENT2	-	-
36	4,5	4.5	Z	-	-	230-233	394_QUEST_clinical_caseMIR	SENT2	-	-
37	g	g	NCMN000	-	-	234-235	394_QUEST_clinical_caseMIR	SENT2	-	-
38	en	en	SPS00	C1720294#C0332285	calificador#atributo	236-238	394_QUEST_clinical_caseMIR	SENT2	-	-
39	orina	orina	NCFS000	C0042036	sustancia	239-244	394_QUEST_clinical_caseMIR	SENT2	-	-
40	de	de	SPS00	C0332285	atributo	245-247	394_QUEST_clinical_caseMIR	SENT2	-	-
41	24	24		-	-	248-250	394_QUEST_clinical_caseMIR	SENT2	-	-
42	h.	h.	NCFS000	-	-	251-253	394_QUEST_clinical_caseMIR	SENT2	-	-
43	En	en	SPS00	C1720294#C0332285	calificador#atributo	254-256	394_QUEST_clinical_caseMIR	SENT2	-	-
44	el	el	DA0MS0	-	-	257-259	394_QUEST_clinical_caseMIR	SENT2	-	-
45	aspirado	aspirado	NC00SC0	C0370199	espécimen	260-268	394_QUEST_clinical_caseMIR	SENT2	-	-
46	medular	medular	AQ0CS0	-	-	269-276	394_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
47	se	se	P00CN000	-	-	277-279	394_QUEST_clinical_caseMIR	SENT2	-	-
48	observó	observar	VMIS3S0	-	-	280-287	394_QUEST_clinical_caseMIR	SENT2	-	-
49	una	una		C0205447_1	calificador_1	288-291	394_QUEST_clinical_caseMIR	SENT2	-	-
50	infiltración	infiltración	NCFS000	C0702249#C0332448	procedimiento#anomalía_morfológica	292-304	394_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
51	del	del	SP+DA	-	-	305-308	394_QUEST_clinical_caseMIR	SENT2	-	-
52	45	45	Z	-	-	309-311	394_QUEST_clinical_caseMIR	SENT2	-	-
53	%	%	Ft	-	-	311-312	394_QUEST_clinical_caseMIR	SENT2	-	-
54	de	de	SPS00	C0332285	atributo	313-315	394_QUEST_clinical_caseMIR	SENT2	-	-
55	células	célula	NCFP000	C1269647#C0007634	célula#estructura_corporal	316-323	394_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
56	plasmáticas	plasmático	AQ0FP0	-	-	324-335	394_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
57	indiferenciadas	indiferenciado	AQ0FP0	C0205618#C0547054	-	336-351	394_QUEST_clinical_caseMIR	SENT2	-	-
58	.	.	Fp	-	-	351-352	394_QUEST_clinical_caseMIR	SENT2	-	-

1	Cuál	cuál	PT0CS000	-	-	353-357	394_QUEST_clinical_caseMIR	SENT3	-	-
2	de	de	SPS00	C0332285	atributo	358-360	394_QUEST_clinical_caseMIR	SENT3	-	-
3	las	el	DA0FP0	-	-	361-364	394_QUEST_clinical_caseMIR	SENT3	-	-
4	siguientes	siguiente	AQ0CP0	C0332282	atributo	365-375	394_QUEST_clinical_caseMIR	SENT3	-	-
5	afirmaciones	afirmación	NCFP000	-	-	376-388	394_QUEST_clinical_caseMIR	SENT3	-	-
6	es	ser	VSIP3S0	-	-	389-391	394_QUEST_clinical_caseMIR	SENT3	-	-
7	cierta	cierto	AQ0FS0	C0205423	calificador	392-398	394_QUEST_clinical_caseMIR	SENT3	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	399-401	394_QUEST_clinical_caseMIR	SENT3	-	-
9	relación	relación	NCFS000	C0456603#C0439849#C3645603	calificador#atributo#metadato_fundacional	402-410	394_QUEST_clinical_caseMIR	SENT3	-	-
10	con	con	SPS00	C0332287	atributo	411-414	394_QUEST_clinical_caseMIR	SENT3	-	-
11	el	el	DA0MS0	-	-	415-417	394_QUEST_clinical_caseMIR	SENT3	-	-
12	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	418-429	394_QUEST_clinical_caseMIR	SENT3	-	-
13	recomendado	recomendar	VMP00SM	-	-	430-441	394_QUEST_clinical_caseMIR	SENT3	-	-
14	en	en	SPS00	C1720294#C0332285	calificador#atributo	442-444	394_QUEST_clinical_caseMIR	SENT3	-	-
15	este	este	DD0MS0	-	-	445-449	394_QUEST_clinical_caseMIR	SENT3	-	-
16	paciente	paciente	NCCS000	C0030705	persona	450-458	394_QUEST_clinical_caseMIR	SENT3	-	-
17	.	.	Fp	-	-	458-459	394_QUEST_clinical_caseMIR	SENT3	-	-

